DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Schwabl P, Hambruch E, Supper P. , et al.
The non-steroidal Fxr agonist Gs-9674 reduces liver fibrosis and ameliorates portal hypertension in a rat NASH model.
J Hepatol 2016;
64 (02) S165-S166
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.